Marvin L. White
Board Member
Aptevo Therapeutics Inc. (APVO)Chairman
Aptevo Therapeutics Inc. (APVO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marvin L. White
Marvin L. White is recorded as Board Member and Chairman at Aptevo Therapeutics Inc. (APVO). Aptevo Therapeutics Inc. reported in an 8-K filed February 3, 2026 that Marvin L. White was appointed Executive Chair of the Board, effective April 1, 2026. Aptevo Therapeutics Inc. reported in an 8-K filed February 3, 2026 that Marvin L. White retired as President and Chief Executive Officer, effective April 1, 2026. The proxy statement of Aptevo Therapeutics Inc. reports total compensation of $1,277,403 for Marvin L. White in fiscal 2025, including a base salary of $630,269. Disclosed compensation is on record for 3 fiscal years.
“On February 3, 2026, the Company announced that effective as of the Transition Date, Mr. White will transition to the role of Executive Chair of the Board”
“On January 30, 2026, Marvin L. White notified Aptevo Therapeutics Inc. (the "Company") of his intent to retire as the Company's President and Chief Executive Officer, effective as of April 1, 2026 (the "Transition Date").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-01–present
-
Current
Start not stated–present
-
Aptevo Therapeutics Inc. (APVO)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2026-04-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aptevo Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Barbara Lopez Kunz CEO, Board Member
- Daniel J. Abdun-Nabi CEO, Board Member
- Jeff Lamothe CEO, Board Member
- Jeffrey G. Lamothe CEO, COO
- Zsolt Harsanyi CEO, Board Member
- John E. Niederhuber Chairman, Board Member
- John Niederhuber, M.D. Chairman
- Daphne Taylor CFO
- SoYoung Kwon General Counsel
- Grady Grant Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aptevo Therapeutics Inc. (APVO) | President and Chief Executive Officer | $630,269 | $1,277,403 |
| 2019 | Aptevo Therapeutics Inc. (APVO) | Chief Executive Officer and President | $547,300 | $974,052 |
| 2018 | Aptevo Therapeutics Inc. (APVO) | Chief Executive Officer and President | $565,123 | $1,104,819 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.